Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of KELENRG
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 157.10 | 135.89 | 96.73 | 95.62 | 122.16 | 128.30 | 102.75 | 117.43 | 139.93 | 143.46 | 117.29 | 128.17 | 143.13 |
| Expenses + | 147.21 | 127.44 | 88.80 | 88.20 | 112.54 | 118.69 | 95.07 | 107.77 | 129.92 | 130.90 | 109.04 | 118.73 | 132.48 |
| Operating Profit | 9.89 | 8.45 | 7.93 | 7.42 | 9.62 | 9.61 | 7.68 | 9.66 | 10.01 | 12.56 | 8.25 | 9.44 | 10.65 |
| OPM % | 6.30% | 6.22% | 8.20% | 7.76% | 7.87% | 7.49% | 7.47% | 8.23% | 7.15% | 8.76% | 7.03% | 7.37% | 7.44% |
| Other Income + | 2.02 | 0.78 | 0.53 | 1.06 | 1.49 | 2.36 | 2.16 | 0.91 | 1.88 | 1.17 | 2.88 | 1.43 | 4.30 |
| Interest | 1.43 | 0.98 | 1.39 | 1.08 | 1.03 | 1.16 | 1.05 | 1.08 | 1.02 | 0.92 | 0.89 | 0.98 | 1.40 |
| Depreciation | 1.51 | 1.63 | 1.69 | 1.77 | 1.67 | 1.74 | 1.78 | 1.76 | 1.71 | 1.81 | 1.82 | 1.88 | 2.13 |
| Profit before tax | 8.97 | 6.62 | 5.38 | 5.63 | 8.41 | 9.07 | 7.01 | 7.73 | 9.16 | 11.00 | 8.42 | 8.01 | 11.42 |
| Tax % | 26.42% | 26.13% | 26.77% | 22.20% | 26.28% | 25.58% | 20.83% | 25.61% | 24.89% | 25.27% | 26.37% | 27.34% | 26.09% |
| Net Profit + | 6.60 | 4.88 | 3.94 | 4.38 | 6.21 | 6.75 | 5.56 | 5.75 | 6.88 | 8.21 | 6.20 | 5.81 | 8.44 |
| EPS in Rs | 66.00 | 48.80 | 39.40 | 43.80 | 62.10 | 67.50 | 55.60 | 57.50 | 68.80 | 82.10 | 62.00 | 58.10 | 84.40 |
Financials of KELENRG
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 192 | 179 | 201 | 202 | 226 | 216 | 220 | 355 | 563 | 449 | 488 | 532 |
| Expenses + | 180 | 166 | 185 | 183 | 211 | 200 | 207 | 340 | 537 | 417 | 451 | 491 |
| Operating Profit | 12 | 13 | 16 | 19 | 15 | 16 | 13 | 15 | 26 | 32 | 36 | 41 |
| OPM % | 6% | 7% | 8% | 10% | 7% | 7% | 6% | 4% | 5% | 7% | 7% | 8% |
| Other Income + | 0 | 1 | 0 | -0 | 1 | -1 | -3 | 2 | 2 | 5 | 8 | 10 |
| Interest | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 5 | 4 | 4 | 4 |
| Depreciation | 4 | 4 | 4 | 5 | 5 | 6 | 5 | 6 | 6 | 7 | 7 | 8 |
| Profit before tax | 5 | 8 | 9 | 11 | 8 | 6 | 3 | 8 | 17 | 26 | 33 | 39 |
| Tax % | 35% | 36% | 35% | 33% | 28% | 24% | 39% | 22% | 29% | 25% | 24% | 26% |
| Net Profit + | 3 | 5 | 6 | 8 | 6 | 5 | 2 | 7 | 12 | 19 | 25 | 29 |
| EPS in Rs | 34.20 | 50.70 | 58.40 | 75.50 | 60.30 | 47.40 | 18.80 | 66.30 | 119.20 | 194.10 | 249.40 | 286.60 |
| Dividend Payout % | 7% | 5% | 4% | 3% | 4% | 3% | 8% | 2% | 1% | 1% | 1% | 1% |
Financials of KELENRG
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 35 | 39 | 44 | 52 | 57 | 61 | 63 | 69 | 80 | 99 | 124 | 152 |
| Borrowings + | 18 | 21 | 24 | 20 | 23 | 23 | 24 | 31 | 32 | 25 | 39 | 72 |
| Other Liabilities + | 44 | 36 | 44 | 39 | 50 | 47 | 54 | 77 | 92 | 98 | 124 | 130 |
| Total Liabilities | 98 | 98 | 113 | 111 | 131 | 132 | 141 | 177 | 205 | 223 | 287 | 355 |
| Fixed Assets + | 45 | 43 | 56 | 56 | 56 | 54 | 54 | 70 | 69 | 71 | 68 | 117 |
| CWIP | 0 | 6 | 1 | 1 | 1 | 3 | 6 | 1 | 1 | 1 | 9 | 38 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 10 | 20 | 22 | 13 |
| Other Assets + | 52 | 49 | 57 | 54 | 74 | 75 | 82 | 100 | 125 | 130 | 188 | 186 |
| Total Assets | 98 | 98 | 113 | 111 | 131 | 132 | 141 | 177 | 205 | 223 | 287 | 355 |
Financials of KELENRG
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 7 | 6 | 13 | 11 | 2 | 5 | 8 | 21 | 18 | 51 | -18 | |
| Cash from Investing Activity + | -2 | -7 | -12 | -4 | -5 | -3 | -7 | -23 | -8 | -17 | -10 | |
| Cash from Financing Activity + | -5 | 1 | -1 | -8 | 4 | -2 | -3 | 2 | -4 | -11 | 10 | |
| Net Cash Flow | 0 | 0 | 0 | -1 | 1 | -0 | -2 | -1 | 6 | 23 | -18 | |
| Free Cash Flow | 5 | -1 | 1 | 6 | -3 | 2 | 0 | 4 | 13 | 27 | -30 | |
| CFO/OP | 79% | 66% | 92% | 75% | 36% | 57% | 68% | 146% | 88% | 185% | -31% |
Financials of KELENRG
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 45 | 59 | 51 | 63 | 64 | 66 | 48 | 40 | 39 | 42 | 42 |
| Inventory Days | 35 | 35 | 43 | 48 | 49 | 56 | 55 | 52 | 33 | 42 | 49 | 49 |
| Days Payable | 79 | 66 | 86 | 70 | 90 | 97 | 107 | 79 | 48 | 78 | 105 | 75 |
| Cash Conversion Cycle | 9 | 14 | 16 | 29 | 21 | 23 | 14 | 21 | 25 | 3 | -14 | 16 |
| Working Capital Days | -8 | -10 | -3 | 4 | -2 | 3 | 4 | -1 | 4 | -14 | -11 | -1 |
| ROCE % | 15% | 18% | 19% | 20% | 14% | 13% | 10% | 12% | 21% | 26% | 26% | 21% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…